Tag: cardioversion
ESC 2019: Maximum-fixed energy shocks are more effective than low-escalating energy...
A study that compared the use of maximum-fixed energy and low-escalating energy shocks for cardioversion in patients with atrial fibrillation (AF) found that maximum-fixed...
Results of phase 3b ENSURE-AF study investigating edoxaban in AF patients...
Daiichi Sankyo has announced it will present the first results from ENSURE-AF, the largest prospective randomised clinical trial to date evaluating a non-vitamin K...
Vernakalant demonstrates 74% cardioversion in post-cardiac surgery patients with atrial fibrillation
A poster presented at the 43rd Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery has shown that vernakalant (Brinavess, Cardiome) successfully cardioverted 74% of atrial fibrillation patients to sinus rhythm at 90 minutes.